UNSPSC 51162008: Aminophylline/guaifenesin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162008 Aminophylline/guaifenesin is a Commodity code that in recent state and local solicitations appears misaligned with its nominal pharmaceutical ingredient scope. The recent opportunities tagged to this code—naloxone and drug-deactivation systems procurement, and on-site pharmacy services delivery—do not match aminophylline/guaifenesin, a bronchodilator respiratory medication. State and local procurement offices appear to use this code inconsistently or as a catch-all for pharmacy-adjacent purchases rather than for the specific active pharmaceutical ingredient the code nominally describes. The work actually being solicited under this code label spans emergency-response pharmaceuticals (naloxone kits for community health), drug-disposal systems, and comprehensive employer pharmacy services including formulary stocking and dispensing across multiple therapeutic categories to insured populations.

Issuing bodies soliciting under this code include county government health departments and county employee benefits offices serving populations ranging from approximately 3,000 covered lives to larger community health initiatives. Seminole County, Florida (IFB 60459723LAS, posted June 30, 2026, response due July 26, 2023) sought 1,900 naloxone units and 800 drug-deactivation systems annually with quarterly deliveries, funded in part through FEMA, requiring electronic bid submission and including a three-month probationary termination clause. Hall County, Georgia (RFQ/P 47-010, posted May 4, 2026, response due June 4, 2026) sought a single on-site pharmacy services vendor to serve approximately 3,005 eligible employees, retirees, and dependents at the County Government Family Health Center, using an 80/20 scoring split favoring technical qualifications over cost, with a one-year initial term and four optional one-year renewals beginning January 1, 2027. Geographic activity appears concentrated in the Southeast (Florida and Georgia in the recent record), though the code's misalignment with its stated pharmaceutical ingredient scope suggests limited meaningful activity under this specific commodity designation.